CoChat

Tau Protein in Cerebrospinal Fluid: A New Diagnostic and Prognostic Marker in Alzheimer Disease?

Mecocci, Patrizia, Cherubini, Antonio, Bregnocchi, Mario, Chionne, Fausto, Cecchetti, Roberta, Lowenthal, David T., Senin, Umberto · 1998 · Alzheimer Disease & Associated Disorders
Cited by 81

The DOI matches its Crossref record.

Abstract

Tau is the main protein of paired helical filaments. It can be detected and measured in cerebrospinal fluid (CSF) and for this reason it has been proposed as a possible in vivo marker of Alzheimer disease (AD). To evaluate the usefulness of CSF tau in the diagnosis of AD we measured it in patients with AD, frontal lobe dementia (FLD), vascular dementia (VD), and in healthy controls by means of a specific enzyme-linked immunosorbent assay test. Individuals with AD had significantly higher tau levels than FLD, VD, and controls. Individuals with late onset AD had significantly higher levels than those with early onset disease. In AD, CSF tau level did not correlate with age, duration, or severity of the disease, whereas a correlation with age was found in FLD and controls. In the nine AD patients in whom CSF tau measurement was repeated after 2 years, mean levels did not differ from baseline, although a worsening of cognitive performances occurred. The overlap among the different groups and the absence of any modification over time suggest that CSF tau measurement, more than in confirming or staging overt AD, might be useful in revealing the disease at its preclinical phase.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00002093-199809000-00015

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 81

Metadata

Authors
Mecocci, P., Cherubini, A., Bregnocchi, M., Chionne, F., Cecchetti, R., Lowenthal, D. T., & Senin, U.
Venue
Alzheimer Disease & Associated Disorders
Published
1998-09
Volume
12
Issue
3
Pages
211-214
ISSN
0893-0341 (ISSN-L)
OpenAlex
W2001844433
Cited by
81
References
0
FWCI
4.72
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tau Protein in Cerebrospinal Fluid: A New Diagnostic and Prognostic Marker in Alzheimer Disease? https://app.cochat.ai/papers/10.1097/00002093-199809000-00015
The paper
Mecocci, P., Cherubini, A., Bregnocchi, M., Chionne, F., Cecchetti, R., Lowenthal, D. T., & Senin, U. (1998). Tau Protein in Cerebrospinal Fluid: A New Diagnostic and Prognostic Marker in Alzheimer Disease? Alzheimer Disease & Associated Disorders. https://doi.org/10.1097/00002093-199809000-00015

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.